An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy

Basit Öğe Kaydı
dc.contributor.authorSevindik, Omur Gokmen
dc.contributor.authorOzkurt, Zubeyde Nur
dc.contributor.authorBoga, Can
dc.contributor.authorBesisik, Sevgi Kalayoglu
dc.contributor.authorIpek, Yildiz
dc.contributor.authorGeduk, Ayfer
dc.contributor.authorOzsan, Guner Hayri
dc.date.accessioned2026-08-12T17:40:15Z
dc.date.issued2021
dc.departmentFırat Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.endpageS103
dc.identifier.issn2152-2650
dc.identifier.issn2152-2669
dc.identifier.startpageS102
dc.identifier.urihttps://hdl.handle.net/11508/59202
dc.identifier.volume21
dc.identifier.wosWOS:000717640800179
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherCig Media Group, Lp
dc.relation.ispartofClinical Lymphoma Myeloma & Leukemia
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleAn interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu